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Abstract
Background: The association between maternal smoking in pregnancy and offspring in-
tellectual disability (ID) is less well understood than that of smoking and fetal growth re-
striction. As fetal growth and cognitive development may share similar confounding
structures, comparison of the two associations may improve understanding of the causal
nature of the association with ID. Furthermore, comparisons of smoking with smokeless
tobacco use may aid identification of mechanisms of action.
Methods: This was a cohort study of all Swedish births between 1999 and 2012
(n¼1 070 013), with prospectively recorded data. We assessed the association between
maternal smoking during pregnancy and offspring outcomes ID and born small for gesta-
tional age (SGA). Analyses were repeated for snus use in pregnancy. Using a sibling de-
sign, we estimated within-family effects that control for shared sibling characteristics.
Results: Those exposed to maternal smoking in pregnancy had increased odds of ID
[odds ratio (OR)¼1.24, 95% confidence interval (CI): 1.16-1.33] and SGA (OR¼ 2.19,
95% CI: 2.11-2.27) after confounder adjustment. Within-family effects were found for
SGA (OR¼1.44, 95% CI: 1.27-1.63) but not ID (OR¼0.92, 95% CI: 0.74-1.14). For snus
use, the results for ID were similar to smoking. We found increased odds of offspring
SGA among mothers who used snus in pregnancy in sensitivity analyses but not in pri-
mary analyses.
VC The Author(s) 2021. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unre-
stricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
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Conclusions: Our findings are consistent with a causal effect of maternal smoking in
pregnancy on risk of offspring born SGA but not on risk of ID. We found no evidence for
a causal effect of snus use in pregnancy on ID and inconclusive evidence for SGA.
Key words: Intellectual disability, fetal growth restriction, maternal prenatal smoking, snus, siblings, confounding
Background
There has been much interest in the cognitive consequences
of exposure to nicotine in pregnancy,1,2 due to its effects
on fetal brain development processes, including neurogene-
sis, migration, differentiation and synaptogenesis.3
However, such associations may be attributable to
confounding.
The association between nicotine exposure in preg-
nancy and extreme cognitive deficits such as intellectual
disability (ID), defined as having an IQ of less than 70
alongside functional impairments,4 has been under-
researched so far. Individuals with ID suffer from poor
long-term outcomes and inequalities compared with the
general population, such as increased mortality,5 socioeco-
nomic disadvantage6,7 and worse access to and effective-
ness of health care.8–11
A systematic review has suggested that smoking during
pregnancy is associated with a small increase in the risk of
offspring ID,12 though the studies included did not ade-
quately account for confounding or information bias.
Three better quality studies not included in the review
found an association between smoking in pregnancy and
offspring risk of ID, but each suggested that this may be
the result of residual confounding.13–15 Further
triangulation of evidence from different causal inference
techniques is required to establish whether such an inter-
pretation is likely.16–18 In contrast, the association between
smoking in pregnancy and offspring fetal growth restric-
tion has strong evidence of being causal in nature, from
complementary causal inference designs.19–21 This latter
association can be used as a positive control for smoking in
pregnancy and offspring ID. By this we mean that, using
the same causal inference methods, if an association is
found for fetal growth restriction but not ID then this will
support the interpretation that observational associations
with ID are the result of residual confounding.If a causal ef-
fect of smoking in pregnancy on ID does exist, then a cross-
context comparison between the associations of snus use
and smoking in pregnancy with offspring ID can be used to
investigate whether effects are the result of nicotine or of the
combustible components of cigarette smoke. Snus is a moist,
smokeless tobacco that is increasingly being used as a smok-
ing cessation aid in Sweden,22,23 with some suggestion that
it is more successful as an aid to stopping smoking than nic-
otine patches or gum.24,25 Snus delivers nicotine in quanti-
ties that are comparable to cigarette smoke though with
slower absorption and higher plasma nicotine concentration
over an extended period.22,26
Key Messages
• Comparison of associations that are suspected to be the result of residual confounding with those that have a strong
body of evidence for being causal can be useful for understanding the causal nature of the former association.
• In this study we used sibling designs to explore the association between maternal smoking in pregnancy and
offspring risk of intellectual disability and compared this with analyses of the association between maternal smoking
in pregnancy and offspring risk of being born small for gestational age (SGA).
• In models that hold fixed genetic and environmental factors shared between siblings, maternal smoking in pregnancy
was associated with risk of being born SGA but not with risk of developing intellectual disability.
• We therefore provide evidence that is not consistent with a causal effect of maternal smoking in pregnancy on
offspring intellectual disability.
• Snus use in pregnancy was not associated with either outcome in primary analyses. Sensitivity analyses did suggest
an association between snus use in pregnancy and offspring SGA but we were unable to provide evidence of the
causal nature of this association.
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Finally, the association between snus use in pregnancy
and offspring fetal growth restriction is of public health
relevance as it may guide whether snus may be a smoking
alternative during pregnancy for those who have difficul-
ties with cessation. Limited research has been performed
on snus use in pregnancy, though evidence of associations
with preterm delivery,27,28 offspring born small for gesta-
tional age (SGA)29 and stillbirth30,31 have been suggested.
Research into snus use in pregnancy and offspring fetal
growth restriction has provided mixed results. Two previ-
ous studies investigating snus use in pregnancy and risk of
offspring born SGA provided no evidence for an associa-
tion,31,32 and another found evidence of increased odds of
SGA for those who used snus before and early into preg-
nancy relative to no use of tobacco products.29 None of
these studies made use of causal inference methods and
may be susceptible to the effects of unmeasured
confounding.
The Swedish data registries provide the opportunity to
use methods to better account for familial confounding
structures. Sibling analyses are a powerful tool as they
hold fixed shared genetic and environmental factors that
can lead to residual confounding. In this project we aimed
to: (i) use conventional analyses to investigate whether ma-
ternal smoking in pregnancy is associated with offspring
risk of intellectual disability; (ii) use sibling analyses to in-
vestigate whether such associations can be accounted for
by characteristics shared between siblings; (iii) use positive
control and cross-context comparisons to learn more about
the nature of the association; and (iv) investigate whether
snus use in pregnancy influences fetal growth restriction.
Methods
The study was approved by the Regional Ethical Review
Board, Stockholm (Dnr: 2016/987–32). The requirement
to obtain informed consent was waived by the Regional
Ethical Review Board, Stockholm (Dnr: 2016/987–32). All
research was performed in accordance with relevant guide-
lines/regulations.
Cohort definition
The study cohort consisted of all individuals born in
Sweden between 1 January 1999 and 31 December 2010
(n¼ 1 181 264; see Figure 1). Information contained in na-
tional registries was linked to cohort members and their
parents. The registries included the Swedish Medical Birth
Registry (MBR),33 the National Patient Registry (NPR)34
and the Swedish Longitudinal Integration Database for
Health Insurance and Labour Market Studies (LISA).35
Data on maternal and paternal identity were obtained
from the Swedish Multi-Generation Register (MGR).36
Most clinical contacts related to intellectual disability
occur in an outpatient setting. The NPR started recording
outpatient contact in addition to inpatient admissions in
2001.34 By defining the start year of the cohort as 1999,
we were able to capture snus use in pregnancy from its ear-
liest recording in the MBR while also capturing diagnoses
from 2 years of age onwards for the oldest members in the
cohort and from an earlier age for all other cohort mem-
bers. We selected 2010 as the end year for inclusion in the
cohort to allow a minimum of 4 years of follow-up until
the end of 2014. The youngest and oldest members of the
cohort were followed up until approximately 4 and
14 years of age, respectively.
Exclusion criteria
Individuals were excluded from the cohort if they: had less
than 4 years of follow-up (e.g. if the individual died before
the age of 4 or had spent less than 4 years living in Sweden;
n¼ 5885); had a genetic or chromosomal abnormality as-
sociated with ID that was identified using ICD-10 diagno-
ses4 in the NPR (specific diagnosis codes provided in
section A1 of the Supplementary Methods, available as
Supplementary data at IJE online; n¼ 9160); or were part
of a multiple birth pregnancy (i.e. twins or triplets etc.;
n¼ 33 558).
Exposure definition: maternal smoking and snus
use during pregnancy
Information about maternal smoking and snus use during
pregnancy was obtained from the MBR for three time
points: (i) 3 months preceding pregnancy; (ii) at the first
antenatal contact (commonly around 10 weeks of preg-
nancy); and (iii) at 30–32 weeks of pregnancy. Further
details of the method of collection of these data and their
validity are provided in the Supplementary Methods, avail-
able as Supplementary data at IJE online (section A2).
Two binary variables were created, one for smoking
and one for snus use, which indicated maternal use at any
point during pregnancy (i.e. either at first antenatal contact
or at 30–32 weeks). Categorical variables for the timing of
exposure were created to indicate those whose mothers: (i)
never smoked/used snus; (ii) used only before pregnancy;
(iii) quit during pregnancy; or (iv) used throughout preg-
nancy. Individuals were excluded from analyses if they
were missing the binary smoking (n¼53 321) or snus
(n¼ 61 968) variables. The total number excluded for
missing exposure data was 62 460.










A binary indicator of ID was defined as having an ICD-10
code of F70-F79, recorded as a primary or secondary diag-
nosis in the NPR. Further details of diagnosis ascertainment
and validity are contained in section A3 of Supplementary
Methods, available as Supplementary data at IJE online.
Fetal growth restriction
Z-scores of birthweight for gestational age were obtained
using the Swedish sex-specific reference curve for normal
fetal growth.37 The MBR contains a binary indicator for
being small for gestational age (SGA), defined as having a
z-score value less than -2 (i.e. two standard deviations be-
low the mean birthweight for a given gender and gesta-
tional age).
Covariate and confounder definitions
The covariates and confounders adjusted for included child
sex and parity, highest education level of either parent at
the time of birth, quintiles of income adjusted for family
size at the time of birth, any maternal or paternal
Figure 1 Flowchart of cohort derivation. Note: an additional 3280 individuals were excluded from small for gestational age (SGA) analyses due to
missing SGA values. These were not removed from intellectual disability (ID) analyses as the SGA values may be missing due to the unobserved
weight for gestational age value, which is on the hypothesized causal path from smoking to ID
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psychiatric disorders before the birth of the child, and ma-
ternal country of origin and age at birth. Specific details of
the confounder derivations are provided in section A4 of
the Supplementary Methods, available as Supplementary
data at IJE online. Individuals were excluded from analy-




We repeated the following analyses for the outcomes ID
and SGA and the exposures maternal smoking in preg-
nancy and maternal snus use in pregnancy. For each expo-
sure-outcome combination we used logistic regression. To
account for cohort effects of differing lengths of follow-up
we adjusted for year of birth in all models that used an out-
come of ID, even those referred to as unadjusted.
We ran four models for each exposure-outcome combi-
nation. Model 1 was unadjusted for any covariates. Model
2 adjusted for covariates and confounders. Model 3 ad-
justed for family-level smoking/snus use by including a
term equal to the proportion of pregnancies in our cohort
in which the mother was recorded as having smoked/used
snus, thus making use of model formulation 2 suggested by
Begg and Parides.38 Model 4 adjusted for all covariates,
confounders and the family-level smoking/snus variable.
Adjustment for a family averaged exposure effect, as in
model 3 and 4, allows the calculation of within-family (co-
efficient of the individual-level exposure) and between-
family (coefficient of the family-level exposure) effects of
smoking on child outcomes. The within-family effect is ro-
bust against confounders that are shared between the sib-
lings. Failing to find a within-family effect after adjustment
for the family-averaged exposure variable is consistent
with familial confounding and there being no causal effect
of the exposure on the outcome.38,39 Sjölander and col-
leagues detail the validity of within-between models for bi-
nary exposures,40 though they note that it is more accurate
to describe the within-family effect as the causal effect
within the exposure-discordant subpopulation. For ease of
terminology we will continue to use the term ‘within-fam-
ily effect’.
The family structure present within the cohort meant
that the data violate the assumption of independence be-
tween observations which can lead to underestimation of
standard errors. All models were therefore run using gener-
alized estimating equations (GEE) with exchangeable cor-
relation structures for family groups identified by having
the same mother. This means that our analyses accounted
for correlations between siblings. Full and half siblings
were treated equivalently. Cousins and other relations
were treated as independent.
Secondary analyses
We assessed whether timing of exposure was associated
with our outcomes. We used four models to assess the as-
sociation and repeated these analyses for the outcomes
SGA and ID. Models 1 and 2, performed unadjusted and
adjusted for confounders, respectively, were logistic regres-
sions using GEE of the outcome on the categorical timing
exposure. Models 3 and 4, again performed unadjusted
and adjusted for confounders, respectively, were condi-
tional logistic regressions of the outcome on the categorical
timing exposure, conditional on family grouping. Models
1 and 2 therefore provide population-averaged estimates,
and Models 3 and 4 provide within-family estimates.
Sensitivity analyses
We performed three sensitivity analyses, described in detail
in section A5 of the Supplementary Methods, available as
Supplementary data at IJE online. Briefly, we examined: (i)
whether inclusion of snus users in the non-smoking com-
parison group (and smokers in the non-snus user compari-
son group) influenced our results; (ii) whether potentially
increased measurement error in the exposure variable
among exposure-discordant siblings influenced our conclu-
sions; and (iii) whether the pattern of change of smoking
across pregnancies (i.e. starting vs stopping smoking) influ-
enced effect estimates, thereby indicating the presence of
carry-over effects.41
Results
Description of the cohort
Descriptive statistics of the cohort, separated by smoking
status and by snus use, are presented in Table 1. Maternal
smoking in pregnancy was more prevalent in the cohort
than snus use in pregnancy (8.78% vs 1.37%). Both smok-
ing and snus use were socially patterned; however, the
strength of that social patterning was greater for smokers.
Smokers were more likely to have low- or mid-level educa-
tion and low income, whereas snus users were more likely
to have mid-level education and mid-level income. Both
smokers and snus users were more likely to have a psychi-
atric disorder diagnosis before the birth of their child.
Smokers [mean: 28.8 years; standard deviation (SD): 5.95]
were younger on average than non-smokers (mean:
30.7 years; SD: 5.00). In comparison, the average age of
snus users (mean: 30.4 years; SD: 5.51) was closer to that
of non-users (mean: 30.6 years; SD: 5.11). Further descrip-
tive results separated by categories of family-level
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Table 1 Cohort characteristics by exposure status during pregnancy
n (%)
Variable Level Non-smokers Smokers Non-snus users Snus users
Total 976 035 (100.00) 93 978 (100.00) 1 055 348 (100.00) 14 665 (100.00)
Intellectual disability No 970 134 (99.40) 92 924 (98.88) 1 048 519 (99.35) 14 539 (99.14)
Yes 5901 (0.60) 1054 (1.12) 6829 (0.65) 126 (0.86)
Small for gestational age No 954 572 (97.80) 89 692 (95.44) 1 029 957 (97.59) 14 307 (97.56)
Yes 18 504 (1.90) 3965 (4.22) 22 152 (2.10) 317 (2.16)
Sex Female 474 465 (48.61) 45 469 (48.38) 512 840 (48.59) 7094 (48.37)
Male 501 570 (51.39) 48 509 (51.62) 542 508 (51.41) 7571 (51.63)
Parity 1 435 909 (44.66) 40 054 (42.62) 469 671 (44.50) 6292 (42.90)
2 362 557 (37.15) 28 990 (30.85) 386 451 (36.62) 5096 (34.75)
3 or more 177 569 (18.19) 24 934 (26.53) 199 226 (18.88) 3277 (22.35)
Highest parental education Pre-age 16 35 861 (3.67) 13 876 (14.77) 49 097 (4.65) 640 (4.36)
Age 16-18 378 936 (38.82) 63 647 (67.73) 434 338 (41.16) 8245 (56.22)
Post-age 18 561 238 (57.50) 16 455 (17.51) 571 913 (54.19) 5780 (39.41)
Adjusted family income 1 102 100 (10.46) 18 644 (19.84) 119 319 (11.31) 1425 (9.72)
2 193 375 (19.81) 32 940 (35.05) 222 371 (21.07) 3944 (26.89)
3 220 396 (22.58) 21 861 (23.26) 238 255 (22.58) 4002 (27.29)
4 231 394 (23.71) 14 066 (14.97) 242 298 (22.96) 3162 (21.56)
5 228 770 (23.44) 6467 (6.88) 233 105 (22.09) 2132 (14.54)
Maternal anxiety diagnosis No 949 353 (97.27) 86 679 (92.23) 1022 267 (96.87) 13 765 (93.86)
Yes 26 682 (2.73) 7299 (7.77) 33081 (3.13) 900 (6.14)
Maternal depression
diagnosis
No 957 545 (98.11) 89 152 (94.86) 1 032 714 (97.86) 13 983 (95.35)
Yes 18 490 (1.89) 4826 (5.14) 22 634 (2.14) 682 (4.65)
Maternal psychosis diagnosis No 973 070 (99.70) 93 089 (99.05) 1 051 612 (99.65) 14 547 (99.20)
Yes 2965 (0.30) 889 (0.95) 3736 (0.35) 118 (0.80)
Maternal addiction
diagnosis
No 965 089 (98.88) 87 978 (93.62) 1 039 026 (98.45) 14 041 (95.74)
Yes 10 946 (1.12) 6000 (6.38) 16 322 (1.55) 624 (4.26)
Any maternal psychiatric
diagnosis
No 929 617 (95.24) 80 419 (85.57) 997 001 (94.47) 13 035 (88.89)
Yes 46 418 (4.76) 13 559 (14.43) 58 347 (5.53) 1630 (11.11)
Any paternal psychiatric
diagnosis
No 942 241 (96.54) 84 672 (90.10) 1 013 191 (96.01) 13 722 (93.57)
Yes 33 794 (3.46) 9306 (9.90) 42 157 (3.99) 943 (6.43)
Any maternal neurodevelop-
mental diagnosis
No 974 771 (99.87) 93 216 (99.19) 1 053 411 (99.82) 14 576 (99.39)
Yes 1264 (0.13) 762 (0.81) 1937 (0.18) 89 (0.61)
Any paternal neurodevelop-
mental diagnosis
No 974 536 (99.85) 93 220 (99.19) 1 053 143 (99.79) 14 613 (99.65)
Yes 1499 (0.15) 758 (0.81) 2205 (0.21) 52 (0.35)
Maternal country of origin Africa 29 178 (2.99) 915 (0.97) 29 985 (2.84) 108 (0.74)
Americas 10 512 (1.08) 658 (0.70) 11 110 (1.05) 60 (0.41)
Asia 30 865 (3.16) 1469 (1.56) 32 116 (3.04) 218 (1.49)
Europe 47 317 (4.85) 7651 (8.14) 54 763 (5.19) 205 (1.40)
Middle East 54 858 (5.62) 4531 (4.82) 59 197 (5.61) 192 (1.31)
Oceania 422 (0.04) 26 (0.03) 443 (0.04) 5 (0.03)
Scandinavia 15 274 (1.56) 2224 (2.37) 17 287 (1.64) 211 (1.44)
Swedish 787 609 (80.69) 76 504 (81.41) 850 447 (80.58) 13 666 (93.19)
Birth year 1999–2001 206 348 (21.14) 20 786 (22.12) 224 778 (21.30) 2356 (16.07)
2002–04 238 757 (24.46) 28 067 (29.87) 262 758 (24.90) 4066 (27.73)
2005–07 248 194 (25.43) 22 508 (23.95) 266 973 (25.30) 3729 (25.43)
2008–10 282 736 (28.97) 22 617 (24.07) 300 839 (28.51) 4514 (30.78)
Any maternal smoking in
pregnancy
No 962 734 (91.22) 13 301 (90.70)
Yes 92 614 (8.78) 1364 (9.30)
Any maternal snus use in
pregnancy
No 962 734 (98.64) 92 614 (98.55)
Yes 13 301 (1.36) 1364 (1.45)
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smoking/snus use, by timing of smoking/snus use and by
patterns of change in smoking status across pregnancy, can
be viewed in the Supplementary Results, section B1, avail-
able as Supplementary data at IJE online.
Missing data assessment
Full details are presented in the Supplementary Results,
section B2, available as Supplementary data at IJE online.
Briefly, missing data in covariates were socially patterned
with those with lower income and education, and those
born in later cohort years more likely to be excluded for
having a missing covariate. Missing data in the exposure
was more likely in those with lower income and less likely
for those born in later cohort years. Smokers were more
likely to have been excluded for having missing snus data
and vice versa. Both diagnosis of ID and being born SGA
were associated with increased risk of exclusion for miss-
ing covariate and exposure data.
Primary analyses
Table 2 shows the results for the primary analyses using
offspring ID as an outcome. Conventional analyses (i.e.
Models 1 and 2) showed that both smoking and snus use
in pregnancy were associated with increased odds of ID
following adjustment for confounders. When separated
into within-family and between-family effects, there was
evidence of between-family but not within-family effects of
smoking and snus use in pregnancy, before and after ad-
justment for confounders.
The results of our primary analyses using offspring SGA
as the outcome are presented in Table 3. Smoking in preg-
nancy was associated with a population-averaged
increased odds of offspring SGA after adjustment for con-
founders. Models 3 and 4 showed that smoking in preg-
nancy was associated with increased odds of SGA for both
the within-family and between-family effects. Snus use in
pregnancy was not associated with offspring SGA in any
model. For most models, the confidence intervals for esti-
mates of the effect of snus use were not compatible with
that of smoking, suggesting that the absence of an associa-
tion between snus use and SGA was not the result of a lack
of power for a rarer exposure.
Secondary analyses
The results for offspring ID are presented in Table 4. An
exposure duration response of increased odds of ID was
found for smoking and using snus later into pregnancy in
conventional models only (Models 1 and 2). In conditional
logistic models that calculated within-family estimates of
the exposure-ID association, no association was found for
smoking for any exposure timing. For smoking (Model 2)
and snus use (Model 1) there was evidence of reduced odds
of ID among those who quit smoking before pregnancy.
Within-family estimates (Models 3 and 4) of the snus use-
ID association showed evidence of decreased odds of ID
among those who quit using snus during pregnancy com-
pared with those who did not use snus at any time.
Table 5 shows the results of our timing analyses for off-
spring SGA as the outcome. Smoking longer into preg-
nancy was associated with a duration-responsive increase
in odds of offspring SGA in conventional and conditional
logistic analyses (Models 1–4). For smoking (Model 2) and
snus use (Models 1 and 2) in pregnancy, there was evidence
for a reduced risk of offspring SGA in conventional models
Table 2 Primary analysis of the association between exposure and offspring intellectual disability (ID)
Smoking in pregnancy Snus use in pregnancy
Model Coefficient ORa 95% CI ORa 95% CI
1. Conventional
unadjustedb
Population-averaged 1.80 (1.68-1.93) 1.36 (1.14-1.63)
2. Conventional
adjustedc
Population-averaged 1.24 (1.16-1.33) 1.28 (1.06-1.52)
3. Within-between
unadjustedb,d
Within-family 0.91 (0.73-1.14) 0.88 (0.60-1.29)
Between-family 2.13 (1.70-2.68) 1.74 (1.14-2.67)
4. Within-between
adjustedc,d
Within-family 0.92 (0.74-1.14) 0.87 (0.59-1.28)
Between-family 1.40 (1.12-1.76) 1.61 (1.05-2.48)
aEstimates produced using a total sample size of 1 070 013 individuals from 703 835 families including 6955 cases of ID.
bModel adjusted for year of birth.
cModel adjusted for year of birth, sex, parity, highest parental education, income, parental psychiatric history, maternal country of origin and maternal age at
birth.
dModel adjusted for family-averaged exposure.
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for mothers who gave up using before pregnancy compared
with those who did not use snus at any time. There was no
other evidence for an association between snus use and off-
spring SGA.
Sensitivity analyses
The results of the sensitivity analyses are presented and de-
scribed in detail in section B3 of the Supplementary
Results, available as Supplementary data at IJE online. The
Table 3 Primary analysis of the association between exposure and offspring born small for gestational age (SGA)
Smoking in pregnancy Snus use in pregnancy
Model Coefficient ORa 95% CI ORa 95% CI
1. Conventional
unadjusted
Population-averaged 2.26 (2.18-2.35) 1.02 (0.92-1.15)
2. Conventional
adjustedb
Population-averaged 2.19 (2.11-2.27) 1.05 (0.94-1.17)
3. Within-between
unadjustedc
Within-family 1.68 (1.50-1.89) 1.01 (0.80-1.26)
Between-family 1.40 (1.23-1.58) 1.02 (0.79-1.33)
4. Within-between
adjustedb,c
Within-family 1.44 (1.27-1.63) 1.07 (0.84-1.36)
Between-family 1.60 (1.41-1.83) 0.98 (0.75-1.29)
aEstimates produced using a total sample size of 1 066 733 individuals from 702 475 families including 22 469 cases of SGA.
bModel adjusted for year of birth, sex, parity, highest parental education, income, parental psychiatric history, maternal country of origin and maternal age at
birth.
cModel adjusted for family-averaged exposure.
Table 4 Secondary analysis of the association between exposure timing and offspring intellectual disability (ID)
Smoking in pregnancy Snus use in pregnancy




User before pregnancy only 1.04 (0.96-1.13) 0.76 (0.60-0.97)
Quit during pregnancy 1.40 (1.19-1.64) 1.07 (0.76-1.50)




User before pregnancy only 0.90 (0.82-0.98) 0.85 (0.67-1.08)
Quit during pregnancy 1.04 (0.88-1.22) 1.04 (0.74-1.47)
Used late into pregnancy 1.17 (1.07-1.28) 1.80 (1.32-2.46)
3. Unadjusted conditional logisticc
(within-family estimates)
Non-user 1.00 1.00
User before pregnancy only 0.94 (0.76-1.16) 0.84 (0.52-1.37)
Quit during pregnancy 0.96 (0.65-1.41) 0.43 (0.19-0.97)
Used late into pregnancy 1.06 (0.75-1.50) 1.06 (0.44-2.54)
4. Adjusted conditional logisticc,d
(within-family estimates)
Non-user 1.00 1.00
User before pregnancy only 0.91 (0.73-1.13) 0.87 (0.53-1.41)
Quit during pregnancy 0.94 (0.63-1.40) 0.41 (0.18-0.94)
Used late into pregnancy 1.00 (0.70-1.43) 0.98 (0.41-2.36)
aEstimates conventional models produced using a total sample size of 1 050 528 individuals from 694 227 families including 6658 cases of ID. Estimates for
conditional logistic models produced using a total sample size of 8412 individuals including 3612 cases of ID.
bEstimates for conventional models produced using a total sample size of 1 063 701 individuals from 700 988 families including 6905 cases of ID. Estimates
for conditional logistic models produced using a total sample size of 8791 individuals including 3762 cases of ID.
cModel adjusted for year of birth.
dModel adjusted for year of birth, sex, parity, highest parental education, income, parental psychiatric history, maternal country of origin and maternal age at
birth.
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repetition of analyses using a cleaner comparison did not
materially change the estimates or conclusions of analyses
for smoking-ID associations, smoking-SGA associations or
snus-ID associations. Using the new comparison group,
unadjusted and adjusted conventional models showed
slightly increased odds of SGA among mothers who used
snus during pregnancy. It is unclear from within-family
and between-family effect estimates whether these associa-
tions were the result of causal effects or residual confound-
ing. The second set of analyses suggested that our
conclusions would not be substantially changed as a result
of increased exposure misclassification among exposure-
discordant families. The third set of analyses showed that
we were able to rule out the influence of carry-over effects
for the outcome ID but not for SGA.
Discussion
We have found evidence that supports a causal role of
smoking in pregnancy on offspring fetal growth restriction,
as measured by SGA, and no evidence of a causal influence
of smoking or snus use in pregnancy on risk of offspring
ID. Both population-averaged and within-family effect
estimates suggested a role of smoking on fetal growth re-
striction. The within-family effect can be interpreted as
meaning that individual-level exposure to maternal smok-
ing in pregnancy, holding fixed shared familial genetics
and environment, is associated with being born SGA.
Maternal smoking and snus use in pregnancy were both as-
sociated with increased population-averaged odds of ID. In
both cases this was shown to be driven by the between-
family effect and not the within-family effect; a finding
that is not consistent with a causal effect. Our primary and
sensitivity analyses provided conflicting evidence for the
causal nature of the association between snus use in preg-
nancy and offspring fetal growth restriction. In primary
analyses no association was found between snus use in
pregnancy and offspring fetal growth restriction, even in
unadjusted conventional models. In sensitivity analyses a
population-averaged effect was suggested, but there was
insufficient precision in sibling analyses to suggest whether
this was the result of within-family or between-family
effects.
The results of our timing analyses supported our con-
clusions of the causal nature of each exposure-outcome as-
sociation. A duration response was found for the within-
family effect estimates of smoking in pregnancy and off-
spring SGA but not for any other investigated association.
We did, however, obtain some unusual results for those
who quit smoking or snus use. Compared with no use, giv-
ing up smoking or snus before pregnancy was associated
with reduced odds of SGA and ID in some conventional
models. Giving up snus during pregnancy was also associ-
ated with reduced odds of ID, using within-family
Table 5 Secondary analysis of the association between exposure timing and offspring born small for gestational age (SGA)
Smoking in pregnancy Snus use in pregnancy




User before pregnancy only 1.04 (1.00-1.09) 0.82 (0.73-0.92)
Quit during pregnancy 1.46 (1.34-1.60) 0.90 (0.74-1.10)




User before pregnancy only 0.90 (0.86-0.94) 0.78 (0.70-0.88)
Quit during pregnancy 1.30 (1.19-1.42) 0.91 (0.75-1.12)
Used late into pregnancy 2.37 (2.26-2.49) 0.96 (0.74-1.23)
3. Unadjusted conditional logistic
(within-family estimates)
Non-user 1.00 1.00
User before pregnancy only 1.77 (1.55-2.03) 1.16 (0.86-1.58)
Quit during pregnancy 2.03 (1.58-2.60) 1.13 (0.72-1.77)
Used late into pregnancy 2.87 (2.30-3.58) 0.96 (0.47-1.96)
4. Adjusted conditional logisticc
(within-family estimates)
Non-user 1.00 1.00
User before pregnancy only 0.97 (0.83-1.12) 0.92 (0.66-1.28)
Quit during pregnancy 1.14 (0.87-1.49) 1.37 (0.83-2.25)
Used late into pregnancy 1.79 (1.42-2.27) 1.39 (0.65-2.97)
aEstimates for conventional models produced using a total sample size of 1 047 385 individuals from 692 911 families including 21 522 cases of SGA.
Estimates for conditional logistic models produced using a total sample size of 21 943 individuals including 9985 cases of SGA.
bEstimates for conventional models produced using a total sample size of 1 060 437 individuals from 699 629 families including 22 310 cases of SGA.
Estimates for conditional logistic models produced using a total sample size of 22 899 individuals including 10 402 cases of SGA.
cModel adjusted for year of birth, sex, parity, highest parental education, income, parental psychiatric history, maternal country of origin and maternal age at
birth.
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estimates. Although a protective effect of nicotine at criti-
cal time points may be possible, we believe that these
results could potentially be explained by the characteristics
of mothers who are able to quit using an addictive sub-
stance at an important time in order to benefit their child’s
health.
Our study strengthens the current body of evidence for
a causal effect of maternal smoking in pregnancy on fetal
growth restriction and provides strong support to the sug-
gestion that the association between smoking in pregnancy
and offspring ID is the result of residual confounding.13–15
To our knowledge, no previous research has investigated
the association between prenatal exposure to snus and off-
spring ID.
Our study used a similar Swedish cohort and an identi-
cal definition of SGA to those in the studies by Baba et
al.,29 who found an association between maternal snus use
in pregnancy and offspring born SGA, and to those of
Wikström et al.31 who did not. Our primary analyses did
not suggest any association between snus use in pregnancy
and offspring risk of SGA, though our sensitivity analyses,
using a potentially cleaner comparison group, suggested
exposure was associated with increased risk. The conflict-
ing results and insufficient precision of the within- and
between-family effect estimates in the sensitivity analysis
mean that further investigation is required to determine if
snus use during pregnancy causally influences the risk of
offspring born SGA.
Strengths and limitations
Our study suffers from limitations that all registry-based
studies are subject to, including potential misclassification,
missing data and residual confounding. A previous study
has shown good validity of measures of smoking during
pregnancy in the MBR,42 though we note that no such
checks of validity have been performed for snus use during
pregnancy. Sensitivity analysis (ii) suggested that our
results would not be substantially changed if there were
high levels of exposure misclassification in the exposure-
discordant group, though we only tested one scenario of
exposure misclassification.
We have used complete case analysis only, which may
be biased for logistic regression when the missing data are
related to both the exposure and the outcome,43 as is the
case for our dataset. Previous work has shown that there is
smaller bias at smaller proportions of missing data.44 The
small quantity of missing data in our dataset may limit the
bias; however, the strong associations between smoking/
snus use status and missing data for snus use/smoking data
may have led to greater quantities of bias. Given that
smokers/snus users and those with ID were both more
likely to have been excluded for missing data, this may
have biased the association towards the null.
Our study attempted to account for residual confound-
ing by using a sibling design which holds fixed shared fa-
milial genetics and environment. We were unable to easily
control for the non-shared confounders of siblings, which
have been shown to bias the results of sibling designs,45
due to the varying size of families. The antenatal nature of
the associations that we are investigating, however, mean
that the non-shared confounders will be limited to changes
in environment between pregnancies, as the mother’s ge-
netics will not change. Sibling designs are also subject to
bias from carry-over effects, for example where the out-
come of the first sibling influences the exposure of the sec-
ond sibling. Our sensitivity analysis ruled out carry-over
effects for ID but was not able to do so for SGA. The bias
arising from such a pattern has been shown to be difficult
to quantify.41
A key strength of our study is the relationship between
the associations investigated. There is strong evidence for a
causal effect of smoking in pregnancy on fetal growth re-
striction, whereas the causal nature of the association be-
tween smoking in pregnancy and ID is unclear. We found
evidence using within-between models of a causal influence
of smoking in pregnancy on fetal growth restriction but
not ID. As this is in line with previous findings, the former
association can be thought of as a positive control of the
latter association, thereby strengthening our confidence in
the evidence produced for the non-causal influence of ex-
posure to maternal smoking in pregnancy on offspring ID.
Further, had a causal effect been suggested, comparison of
the influence of smoking and snus use in pregnancy on off-
spring ID would have provided a cross-context comparison
which could have been useful for identifying whether nico-
tine or combustible components of smoking were involved
in biological mechanisms.
In conclusion, our study has provided no evidence for a
causal effect of smoking or snus use in pregnancy on risk
of offspring ID, instead suggesting that associations are the
result of residual confounding. We found conflicting evi-
dence regarding whether snus use in pregnancy is associ-
ated with the risk of offspring being born SGA. Neither
finding suggests that smoking or snus use in pregnancy is
safe. Smoking in pregnancy has well established negative
effects on offspring health, whereas research into snus use
in pregnancy is in its infancy. Further assessments of the
health costs and benefits of snus use in pregnancy relative
to smoking need to be performed before guidance can be
given regarding whether snus use is a suitable alternative
to smoking or even whether it should be used as a cessation
aid during this period.
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